SELECT follow-up study to evaluate Long-term Impact oF anti-obEsity medication(EX9536-4750)
Not Applicable
Recruiting
- Conditions
- subjects with established CV disease and overweight or obesity
- Registration Number
- JPRN-jRCT1031230250
- Lead Sponsor
- Okada Takumi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 110
Inclusion Criteria
1. Randomized into the SELECT clinical trial (EX9536-4388) and has not withdrawn consent, regardless of level of participation, dose achieved or treatment discontinuation.
2. Signed SELECT-LIFE consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
Exclusion Criteria
Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Death, Myocardial infarction, Stroke, Type 2 diabetes diagnosis, Concomitant medication, Body weight, Cancer and its location, Treatment for overweight or obesity, Surgery for knee replacement, Hospitalisation, Quality of life (EQ-5D-5L), Sleep apnoea
- Secondary Outcome Measures
Name Time Method